Heart surgery is done to correct problems with the heart. More than half a million heart surgeries are done each year in the United States for a variety of heart problems. Heart surgery is used to correct heart problems in children and adults. This article discusses heart surgeries for adults. For more information about heart surgeries for children, see the Diseases and Conditions Index articles on congenital heart defects, holes in the heart, and tetralogy of Fallot.
The most common type of heart surgery for adults is coronary artery bypass grafting (CABG). During CABG, surgeons use healthy arteries or veins taken from another part of the body to bypass (that is, go around) blocked arteries. CABG relieves chest pain and reduces the risk of heart attack.
In laboratory tests in dogs, cardiac researchers at Washington University School of Medicine in St. Louis have found that treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation. They report their findings in the June 7 issue of Circulation.
A study of nearly 60,000 patients has found that people with several clogged heart arteries did better if they had bypass surgery rather than a less-drastic procedure in which the blood vessels are propped open with tiny mesh cylinders called stents.
Duke University Medical Center researchers have found that patients who were using a class of anti-depression drugs known as selective serotonin reuptake inhibitors (SSRI) prior to undergoing coronary artery bypass surgery have significantly higher death and rehospitalization rates up to five years after the procedure than patients who were not on SSRIs.
Duke University Medical Center researchers have found that the presence of specific variants of genes that control clotting and the contractility, or "tone," of blood vessels can double the ability of physicians to predict those heart surgery patients at greatest risk of bleeding after surgery.
For over 20 years, routine data sources such as the hospital episode statistics have been widely perceived as being of little value because of problems with completeness and accuracy, and the Department of Health has in the past dismissed their use for identifying poor quality services.
On March 31, Joel Dyels celebrated his 72nd birthday by having coronary bypass surgery at Stanford Hospital. He also became the third patient at Stanford - and in the United States - to benefit from a new imaging system that lets doctors see the blood pathways they have created while the patient's chest is still open.
Despite an expert panel stating last month that the three COX-2 drugs Vioxx, Bextra and Celebrex were safe enough to be marketed, the U.S. Food and Drug Administration (FDA) has this week told drug manufacturer Pfizer to remove the drug Bextra from the market and a statement by Pfizer confirms that the European Union regulators have done the same.
Researchers have found a novel protein marker that can give a rapid and early diagnosis of kidney failure in children undergoing heart surgery, reporting their results in this week’s issue of The Lancet.
An experimental procedure marks the launch of a research study approved by the Food and Drug Administration in January. The breakthrough technology could save the lives of thousands of people with heart valve disease who have no other treatment options. In a new clinical trial the first U.S. patient has received a heart valve implant without open-heart surgery.
Twenty five heart surgeons in Northwest England publish their individual mortality rates in this week's BMJ. The results show that all surgeons are performing to satisfactory standards.
When a young child is in need of a heart transplant, the problem is not the intricate surgery, but the scarcity of donors.
Specific variants of genes involved in inflammation and blood vessel constriction are strongly associated with kidney damage in patients undergoing major heart surgery, researchers at Duke University Medical Center have found.
The Swedish research team studied 102 women under the age of 75, all of whom had survived a heart attack or heart surgery for blocked arteries. All participants were asked to record their alcohol intake for one week after a year.
Individuals with moderate to severe chest pains (angina) who have not found relief from medication may benefit from a new gene therapy approach being used by cardiologists at Rush University Medical Center to grow new blood vessels in the heart.
In recent years, children's hospitals have joined in the national push to improve patient safety and avoid preventable problems. But it has been hard to measure progress, because of uncertainty about whether standard patient safety measurement tools apply to their patients, who are younger, smaller and on average sicker than those at other hospitals.
The Food and Drug Administration (FDA) has issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents.
Researchers in Aberdeen have launched a study to see whether a new blood test can better predict the outcome for patients facing heart surgery.
Since she was a young girl, Sandra Moore, 46, of Glen Ellyn, Ill., had episodes every few months when her heart started racing.
The Hospital of the University of Pennsylvania (HUP) is participating in a nationwide clinical trial of a new valve repair device that could replace major heart surgery in some patients.
Researchers at Johns Hopkins have shown that genetic testing can be effectively used to distinguish between heart failure patients who suffer from ischemic or nonischemic forms of the disease.